The Annals Holiday Offer - Save 50%
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 14 October 2005, www.theannals.com, DOI 10.1345/aph.1G161.
The Annals of Pharmacotherapy: Vol. 39, No. 12, pp. 2026-2028. DOI 10.1345/aph.1G161
© 2005 Harvey Whitney Books Company.
This Article
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Trissel, L. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Trissel, L. A

ONCOLOGY

Physical and Chemical Stability of Pemetrexed Solutions in Plastic Syringes

Yanping Zhang, BS1, and Lawrence A Trissel, BS FASHP2

1 Research Investigator, Pharmacy Laboratory, The University of Texas, MD Anderson Cancer Center, Houston, TX
2 Director, Clinical Pharmaceutics Research, Division of Pharmacy, The University of Texas, MD Anderson Cancer Center

Reprints: Mr. Trissel, Division of Pharmacy, Unit 090, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030-4095, fax 713/563-2958

BACKGROUND: Pemetrexed is a multitargeted antifolate antineoplastic agent that is indicated for single-agent use in advanced or metastatic non-small-cell lung cancer and in combination with cisplatin for the treatment of malignant pleural mesothelioma not treatable by surgery. Currently, there is no information on the long-term stability of pemetrexed solutions beyond 24 hours.

OBJECTIVE: To evaluate the stability of pemetrexed reconstituted with NaCl 0.9% injection to a concentration of 25 mg/mL and packaged in polypropylene syringes.

METHODS: Triplicate samples of reconstituted pemetrexed 25 mg/mL were packaged in 20-mL polypropylene syringes and evaluated for physical and chemical stability performed initially and over 2 days of storage at 23 °C and over 31 days of storage at 4 °C. Physical stability was assessed using turbidimetric and particulate measurement, as well as visual observation. Chemical stability was evaluated by HPLC.

RESULTS: The reconstituted pemetrexed solutions remained physically and chemically stable throughout the respective study periods, with no precipitation or color change and little or no loss of pemetrexed.

CONCLUSIONS: Pemetrexed reconstituted with NaCl 0.9% to a concentration of 25 mg/mL packaged in polypropylene syringes was found to be stable for 2 days at room temperature and 31 days refrigerated.

Key Words: Alimta, pemetrexed, stability, syringe

Published Online, October 14, 2005. www.theannals.com, DOI 10.1345/aph.1G161


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
Y. Zhang and L. A Trissel
Physical Instability of Frozen Pemetrexed Solutions in PVC Bags
Ann. Pharmacother., July 1, 2006; 40(7): 1289 - 1292.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2005 by Harvey Whitney Books Company.